98 related articles for article (PubMed ID: 24623240)
1. Detection of point mutations of K-ras oncogene and p53 tumor-suppressor gene in sputum samples.
Gao W; Keohavong P
Methods Mol Biol; 2014; 1105():325-44. PubMed ID: 24623240
[TBL] [Abstract][Full Text] [Related]
2. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.
Keohavong P; Gao WM; Zheng KC; Mady H; Lan Q; Melhem M; Mumford J
Anal Biochem; 2004 Jan; 324(1):92-9. PubMed ID: 14654050
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Mutations in K-ras and p53 Genes in Sputum and Plasma Samples.
Zhang L; Gao W; Keohavong P
Methods Mol Biol; 2020; 2102():373-394. PubMed ID: 31989568
[TBL] [Abstract][Full Text] [Related]
4. Analysis of K-RAS and P53 mutations in sputum samples.
Gao W; Keohavong P
Methods Mol Biol; 2005; 291():217-33. PubMed ID: 15502226
[TBL] [Abstract][Full Text] [Related]
5. Gene mutation analysis in non-small cell lung cancer patients using bronchoalveolar lavage fluid and tumor tissue as diagnostic markers.
Li J; Hu YM; Wang Y; Tang XP; Shi WL; Du YJ
Int J Biol Markers; 2014 Dec; 29(4):e328-36. PubMed ID: 24519547
[TBL] [Abstract][Full Text] [Related]
6. Analysis of EGFR, KRAS and P53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy.
Yamaguchi F; Kugawa S; Tateno H; Kokubu F; Fukuchi K
Lung Cancer; 2012 Dec; 78(3):201-6. PubMed ID: 23026641
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
8. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
9. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
[TBL] [Abstract][Full Text] [Related]
10. Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China.
Keohavong P; Lan Q; Gao WM; Zheng KC; Mady HH; Melhem MF; Mumford JL
Carcinogenesis; 2005 Feb; 26(2):303-8. PubMed ID: 15564291
[TBL] [Abstract][Full Text] [Related]
11. p53 and K-ras mutations in lung tissues and sputum samples of individuals exposed to smoky coal emissions in Xuan Wei County, China.
Keohavong P; Lan Q; Gao W
Mutat Res Genet Toxicol Environ Mutagen; 2018; 829-830():70-74. PubMed ID: 29704996
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
13. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
15. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions.
Minamoto T
Methods Mol Biol; 2014; 1105():381-98. PubMed ID: 24623243
[TBL] [Abstract][Full Text] [Related]
16. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers.
Kitagawa Y; Wong F; Lo P; Elliott M; Verburgt LM; Hogg JC; Daya M
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):45-54. PubMed ID: 8679221
[TBL] [Abstract][Full Text] [Related]
18. Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.
Ulivi P; Romagnoli M; Chiadini E; Casoni GL; Capelli L; Gurioli C; Zoli W; Saragoni L; Dubini A; Tesei A; Amadori D; Poletti V
Int J Oncol; 2012 Jul; 41(1):147-52. PubMed ID: 22504767
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT.
Somers VA; Pietersen AM; Theunissen PH; Thunnissen FB
J Clin Oncol; 1998 Sep; 16(9):3061-8. PubMed ID: 9738576
[TBL] [Abstract][Full Text] [Related]
20. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
